A distinct set of prognosticators were identified for HPV+ and HPV- oropharyngeal cancers; ECHDC2, GGT6, HERC5 were showed to be associated with HPV+; HERC5 has a known anti-viral activity [78] [79] and its possible role in HNSCC HPV associated cancer is yet to be studied. Here, ECHDC2 is linked to oropharynx cancer.